Genzyme Successfully Meets First Milestones of FDA Consent Decree
All Filling and Finishing for U.S. Market Transferred Out of Allston Plant
30-Nov-2010 -
Genzyme Corporation announced that the company has ended fill/finish operations within its Allston plant for products sold in the United States, as required by the FDA consent decree. All fill/finish activities for Cerezyme® (imiglucerase for injection), Myozyme® (alglucosidase alfa), Fabrazyme® ...
fillings
Genzyme
Ireland